Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial
Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0142|121|10|1654-1661
ISSN: 0008-543x
Source: CANCER, Vol.121, Iss.10, 2015-05, pp. : 1654-1661
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract